Abstract

The neuromuscular acetylcholine (ACh) receptor has two conserved prolines in loop D of the complementary subunit at each of its two transmitter-binding sites (α-ε and α-δ). We used single-channel electrophysiology to estimate the energy changes caused by mutations of these prolines with regard to unliganded gating (ΔG0) and the affinity change for ACh that increases the open channel probability (ΔGB). The effects of mutations of ProD2 (εPro-121/δPro-123) were greater than those of its neighbor (εPro-120/δPro-122) and were greater at α-ε versus α-δ. The main consequence of the congenital myasthenic syndrome mutation εProD2-L was to impair the establishment of a high affinity for ACh and thus make ΔGB less favorable. At both binding sites, most ProD2 mutations decreased constitutive activity (increased ΔG0). LRYHQG and RL substitutions reduced substantially the net binding energy (made ΔGB(ACh) less favorable) by ≥2 kcal/mol at α-ε and α-δ, respectively. Mutant cycle analyses were used to estimate energy coupling between the two ProD2 residues and between each ProD2 and glycine residues (αGly-147 and αGly-153) on the primary (α subunit) side of each binding pocket. The distant binding site prolines interact weakly. ProD2 interacts strongly with αGly-147 but only at α-ε and only when ACh is present. The results suggest that in the low to-high affinity change there is a concerted inter-subunit strain in the backbones at εProD2 and αGly-147. It is possible to engineer receptors having a single functional binding site by using a α-ε or α-δ ProD2-R knock-out mutation. In adult-type ACh receptors, the energy from the affinity change for ACh is approximately the same at the two binding sites (approximately -5 kcal/mol).

Highlights

  • Mutation of a proline at the acetylcholine receptor (AChR) transmitter-binding site causes a congenital myasthenic syndrome

  • The results suggest that in the low to-high affinity change there is a concerted inter-subunit strain in the backbones at ⑀ProD2 and ␣Gly-147

  • 2) The congenital myasthenic syndrome (CMS) mutation ⑀ProD2-L is analyzed according to a cyclic model of activation to estimate the high affinity equilibrium dissociation constant for ACh. 3) 25 different side chain substitutions of ProD2 at ␣-⑀ and ␣-␦ are quantified with regard to their effects on ⌬G0 and ⌬GBACh. 4) Mutant cycle analyses reveal the degree of energy coupling between the two binding sites and between ProD2 and ␣ subunit glycines at each binding site, both with and without ACh present

Read more

Summary

Background

Mutation of a proline at the AChR transmitter-binding site causes a congenital myasthenic syndrome. We report the functional consequences of mutations of the AChR prolines at both the ␣-⑀ and ␣-␦ transmitter-binding sites, with regard to both the energy of unliganded gating (⌬G0) and the energy from the affinity change for the transmitter (⌬GBACh) The sum of these two quantities is equal to the energy difference between A2O and A2C (where A is the agonist), and it determines the diliganded gating equilibrium constant and the maximum open channel probability (see “Experimental Procedures”). A leucine substitution at ⑀ProD2 causes a congenital myasthenic syndrome (CMS) and has been studied previously at the single-channel level in human AChRs [8] This mutation decreases the resting affinity of the ␣-⑀ transmitter-binding site by ϳ40-fold and the diliganded gating equilibrium constant by nearly 300-fold. The results are presented in five sections. 1) We describe a method to measure the change in ⌬GBACh caused by a ProD2 mutation at just one binding site. 2) The CMS mutation ⑀ProD2-L is analyzed according to a cyclic model of activation to estimate the high affinity equilibrium dissociation constant for ACh. 3) 25 different side chain substitutions of ProD2 at ␣-⑀ and ␣-␦ are quantified with regard to their effects on ⌬G0 and ⌬GBACh. 4) Mutant cycle analyses reveal the degree of energy coupling between the two binding sites and between ProD2 and ␣ subunit glycines at each binding site, both with and without ACh present. 5) We engineer AChRs to have a single functional binding site and estimate ⌬GBACh from ␣-⑀ and ␣-␦, independently

EXPERIMENTAL PROCEDURES
RESULTS
35 Ϯ 1 25 Ϯ 5 385 Ϯ 17 57 Ϯ 13 2068 Ϯ 83 47 Ϯ 1 2000 Ϯ 197 249 Ϯ 18
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call